Advantages of a new anticoagulant in routine hematology on the Coulter Counter S-Plus STKR analyzer.
Where this comes from
- Record sourced from PubMed, PMID 2111970.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors report the advantages of a new anticoagulant-antiaggregant mixture that avoids the deleterious effects of ethylenediaminotetraacetic acid (EDTA) on mean platelet volume and also prevents EDTA-induced platelet clumping. It is suitable for routine cell counting and sizing with the Coulter Counter S-Plus STKR. The values of the common hematologic parameters agree well with those from EDTA-treated samples and are stable for at least eight hours after sampling.
Medical subject headings
- Anticoagulants
- Blood Cell Count
- Citrates
- Pyridoxal Phosphate
- Tromethamine